zadnja posodobitev :
19/11/2024
Protivnetno zdravilo   Budesonide  
Peroralna raztopina
Aerosol
Stabilnost farmacevtskih preparatov Stabilnost mešanice Faktorji, ki vplivajo na stabilnost Kompatibilnost Viri pdf
   Kemična formula  

Peroralna raztopina
Viri   Peroralna raztopina   Viri : Budesonide  
Tip objava
4001 časopis Ip K,Carvalho M,Shan A,Banov D.
Physical and Chemical Stability of Budesonide Mucoadhesive Oral Suspensions (MucoLox).
Int J Pharm Compound 2017 ; 21:4 :322-329
4101 časopis Ey C, Hosselet C, Villon B, Mar?on F.
Paediatric formulation: budesonide 0.1 mg/mL viscous oral solution for eosinophilic esophagitis using cyclodextrins.
Pharmaceutical Technology in Hospital Pharmacy 2018
4104 časopis Bonnet M, Dermu M, Roessle C, Bellaiche M, Abarou T, Vasseur V, Benakouche S, Storme T.
Formulation of a 3-months Stability Oral Viscous Budesonide Gel and Development of an Indicating Stability HPLC Method.
Pharmaceutical Technology in Hospital Pharmacy 2018

  Mentions Légales